Cite Filings / ACAD / 0001564590-22-016850

Feed Companies Filings Check

Sign in

DEF 14A

Proxy Statement

ACADIA PHARMACEUTICALS INC Filed 2022-04-29 Acc 0001564590-22-016850

Documents 1

DEF 14A Proxy Statement , acad-def14a_20220607.htm

Around this filing

2023-05-01 DEF 14A Proxy Statement
2022-05-03 4 CEO sold 5,483 shares at $18.18 ($99,691)
2022-05-03 4 President sold 2,865 shares at $18.18 ($52,091)
2022-05-03 4 EVP,General Counsel, Secretary sold 894 shares at $18.18 ($16,255)
2022-05-03 4 EVP, COO, Head of Commercial sold 552 shares at $18.18 ($10,036)
2022-04-29 DEF 14A Proxy Statement
2021-04-30 DEF 14A Proxy Statement

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading acad-def14a_20220607.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…